Lighthouse Financial’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.78M Buy
17,966
+8,496
+90% +$1.7M 1.7% 20
2026
Q2
$1.8M Buy
9,470
+1,610
+20% +$277K 0.93% 28
2026
Q1
$1.33M Buy
7,860
+4,850
+161% +$829K 0.8% 26
2025
Q4
$508K Hold
3,010
– – 0.33% 39
2025
Q3
$435K Hold
3,010
– – 0.29% 49
2025
Q2
$381K Sell
3,010
-200
-6% -$24.6K 0.29% 50
2025
Q1
$411K Hold
3,210
– – 0.35% 43
2024
Q4
$424K Buy
+3,210
New +$451K 0.34% 45

Other funds holding IBB

Lighthouse Financial's IBB Position: Q3 2026 in Review

Lighthouse Financial increased its iShares Biotechnology ETF (IBB) stake by 90% in Q3 2026, buying an estimated $1.7M and bringing the position to 17,966 shares worth $3.78M. The position accounts for 1.7% of the portfolio, ranked #20.

Lighthouse Financial first reported a position in IBB in Q4 2024 and has held it in 8 quarters since. 434 funds tracked by Wall St. Rank hold IBB as of Q3 2026.

  • Lighthouse Financial held 17,966 shares of iShares Biotechnology ETF worth $3.78M as of Q3 2026.
  • Lighthouse Financial bought 8,496 iShares Biotechnology ETF shares in Q3 2026, an estimated $1.7M.
  • iShares Biotechnology ETF made up 1.7% of Lighthouse Financial's portfolio in Q3 2026, its #20 holding.
  • Lighthouse Financial first reported a position in iShares Biotechnology ETF in Q4 2024 and has held it in 8 quarters since.
  • 434 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.

Based on Lighthouse Financial's 13F filing for Q3 2026, filed 23 Oct 2026.